By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Seqirus, A CSL Company 

One Health Plaza
East Village Promenade

310/4th floor
East Hanover  New Jersey  07936-1080  U.S.A.
Phone: 1-919-577-5000 Fax: n/a


In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine company in the world.

With research and production expertise and manufacturing plants in the US, UK, Germany and Australia, Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.

Seqirus has a corporate office in Maidenhead, United Kingdom.




All Products

Key Statistics

Ownership: Private

Web Site: Seqirus

Company News
Seqirus Receives FDA Approval Of Afluria Quadrivalent (Influenza Vaccine) For People Five Years Of Age And Older In The U.S. 9/14/2017 9:58:58 AM
Seqirus Donates Influenza Vaccine For Hurricane Harvey Relief In Texas 9/13/2017 11:55:44 AM
Seqirus Release: Canadian Parents Willing To Vaccinate Their Infants With Adjuvanted Influenza Vaccine, Study Finds 9/11/2017 11:51:11 AM
Seqirus Release: New Phase III Study Shows Significantly Greater Efficacy In Children 6-24 Months Who Receive Adjuvanted Influenza Vaccine (Aqiv) 9/11/2017 11:49:08 AM
Seqirus Announces Major Advances In Pandemic Preparedness 8/8/2017 7:30:28 AM
Seqirus Begins Shipping 2017-2018 Influenza Vaccines To The U.S. Market 7/20/2017 7:43:36 AM
Seqirus Announces Next Major Advancement In Cell-Based Influenza Vaccine Technology 6/21/2017 8:07:40 AM
Seqirus and Zambon Release: Companies Enter Into A Partnership For Parkinson’s Disease Product In Australia And New Zealand 1/10/2017 10:58:00 AM
Seqirus Presents Analysis Reinforcing The Safety And Immunogenicity Profiles Of Its MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine In Adults 65 Years And Older 8/29/2016 11:03:17 AM
PaxVax, Inc. Inks Swiss Marketing And Distribution Agreement With Seqirus For Influenza Vaccines 8/29/2016 10:24:51 AM